Literature DB >> 6456885

Comparison of the activity of cefoperazone, cefuroxime and cefoxitin against Gram-negative bacilli and synergy studies with cefoperazone and ticarcillin.

H M Miles, M Carson, E R Pavillard.   

Abstract

83% of at least 11 different species of Gram-negative aerobic bacilli, comprising 270 clinical isolates, were inhibited by 3.1 microgram cefoperazone per ml. 55% and 48% were inhibited by 3.1 micrograms/ml of cefuroxime and cefoxitin, respectively. In addition, cefoperazone inhibited 83 of 96 Pseudomonas aeruginosa isolates at a concentration of 6.2 microgram/ml. Cefoperazone/ticarcillin combinations were shown to be synergistic for 47/96 (49%) of Pseudomonas aeruginosa isolates studied, when lowering of the minimum bactericidal concentrations of the 2 drugs was the criterion for enhancement of activity. Cefoperazone/ticarcillin combinations were also shown to be synergistic against 15/30 Serratia marcescens isolates. We discuss the possible advantages of synergistic combinations of drugs of relatively low toxicity, for the management of complicated infections.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456885     DOI: 10.2165/00003495-198100221-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  4 in total

1.  Cefoperazone: absorption, excretion, distribution, and metabolism.

Authors:  K Shimizu
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

2.  A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa.

Authors:  E R Pavillard; H Miles
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

3.  Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.

Authors:  A L Barry; C Thornsberry; R N Jones; P C Fuchs; T L Gavan; E H Gerlach
Journal:  Am J Clin Pathol       Date:  1978-12       Impact factor: 2.493

4.  Comparative activity and beta-lactamase stability of cefoperazone, a piperazine cephalosporin.

Authors:  H C Neu; K P Fu; N Aswapokee; P Aswapokee; K Kung
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

  4 in total
  2 in total

1.  Effect of aztreonam in combination with azlocillin or piperacillin on Pseudomonas aeruginosa.

Authors:  D H Wu; A L Baltch; R P Smith; P E Conley
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

Review 2.  Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.